How should Barrett's ulceration be treated?
Peters
J H
JH
Department of Surgery, University of Southern California, Los Angeles 90033, USA. jhpeters@surgery.usc.edu
Wang
K K
KK
D000230:Adenocarcinoma / Q000209:etiology / Q000517:prevention & control; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D002986:Clinical Trials as Topic; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control; D004941:Esophagitis / Q000188:drug therapy / Q000209:etiology; D018662:Fundoplication; D005764:Gastroesophageal Reflux / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D010535:Laparoscopy; D011230:Precancerous Conditions / Q000601:surgery / Q000628:therapy; D011446:Prospective Studies; D054328:Proton Pump Inhibitors; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D016896:Treatment Outcome; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*
D000863:Antacids; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors